Classification and application of metal-based nanoantioxidants in medicine and healthcare

• Nguyen Nhat Nam,
• Nguyen Khoi Song Tran,
• Tan Tai Nguyen,
• Nguyen Ngoc Trai,
• Nguyen Phuong Thuy,
• Hoang Dang Khoa Do,
• Nhu Hoa Thi Tran and
• Kieu The Loan Trinh

Beilstein J. Nanotechnol. 2024, 15, 396–415, doi:10.3762/bjnano.15.36

• because most drugs cannot cross the blood–brain barrier (BBB) [115][116]. Besides, the accumulation of drugs at damaged areas of the BBB can lead to an unprotected, disrupted BBB and to disturbances of the brain microenvironment. In contrast, the integrity of the BBB can decrease the accumulation of drugs

• other medicines, which significantly limits their applications in clinical practice. Some common barriers include blood–brain barrier, gastrointestinal barrier, cellular membrane, and blood vessel fenestration [195]. Although scientists have made significant effort in solving this problem, only a few

Elasticity, an often-overseen parameter in the development of nanoscale drug delivery systems

• Agnes-Valencia Weiss and
• Marc Schneider

Beilstein J. Nanotechnol. 2023, 14, 1149–1156, doi:10.3762/bjnano.14.95

• barriers besides cellular membranes need to be addressed. A few examples of these barriers are penetration in or permeation through mucus, skin penetration, overcoming the blood brain barrier, or extravasation from blood vessels. Another challenge is the accumulation of particulate drug delivery systems in

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• smaller when proteins were bound to NPs [81]. Xiao et al. functionalized Tf onto the surface of PEGylated polystyrene NPs to evaluate the effect of the protein corona on blood–brain barrier transcytosis, endocytosis, and intracellular trafficking. They demonstrated that Tf-NPs completely lost their

Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities

• Akif Hakan Kurt,
• Elif Berna Olutas,
• Fatma Avcioglu,
• Hamza Karakuş,
• Mehmet Ali Sungur,
• Cansu Kara Oztabag and
• Muhammet Yıldırım

Beilstein J. Nanotechnol. 2023, 14, 362–376, doi:10.3762/bjnano.14.31

• conventional treatments. This resistance is mostly due to the blood–brain barrier, which is the most important obstacle to drug distribution. Since nanoparticles can penetrate through the blood–brain barrier, they are a preferred medicine in brain and nervous system diseases. In glioblastoma multiforme

Polymer nanoparticles from low-energy nanoemulsions for biomedical applications

• Santiago Grijalvo and
• Carlos Rodriguez-Abreu

Beilstein J. Nanotechnol. 2023, 14, 339–350, doi:10.3762/bjnano.14.29

• showed that the PLGA nanoparticles functionalized with 8D3 antibody were able to cross the blood–brain barrier (BBB) as demonstrated by the analgesic effect of encapsulated loperamide on mice. PLGA nanoparticles prepared using Polysorbate 80 with the same formulation discussed above (diameter ca. 27 nm

Overview of mechanism and consequences of endothelial leakiness caused by metal and polymeric nanoparticles

• Magdalena Lasak and
• Karol Ciepluch

Beilstein J. Nanotechnol. 2023, 14, 329–338, doi:10.3762/bjnano.14.28

• (CNS), where endothelial cells form the tightest and the most selective blood–brain barrier (BBB) that provides protection against the penetration of harmful substances and pathogens. Other types of connections include adherens junctions, maintained primarily by transmembrane VE-cadherin, and gap

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• cells have also been found to have the ability to penetrate the blood‒brain barrier (BBB) in some special cases [26][27]. As a highly specialized structure, the BBB maintains homeostasis of the central nervous system [48]. The targeted delivery of drugs to the brain is challenging because of the limited

Engineered titania nanomaterials in advanced clinical applications

• Padmavati Sahare,
• Paulina Govea Alvarez,
• Juan Manual Sanchez Yanez,
• Gabriel Luna-Bárcenas,
• Samik Chakraborty,
• Sujay Paul and
• Miriam Estevez

Beilstein J. Nanotechnol. 2022, 13, 201–218, doi:10.3762/bjnano.13.15

• small size of nanomaterials enables them to permeate through biological barriers in the body, such as the blood–brain barrier, the pulmonary system, and through the tight junction of endothelial cells of the skin. The main goal of loading drugs on nanomaterials is the delivery to specific target cells

Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• , which yielded a dual targeting structure that was able to cross the blood–brain barrier, a significant obstacle when treating brain tumors. Similarly, an improved internalization of CUR-loaded MNP was also observed in HPAF-II and Panc-1 human pancreatic cancer cell lines (54.06% and 53.86%, respectively

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Transient coating of γ-Fe₂O₃ nanoparticles with glutamate for its delivery to and removal from brain nerve terminals

• Konstantin Paliienko,
• Artem Pastukhov,
• Michal Babič,
• Daniel Horák,
• Olga Vasylchenko and
• Tatiana Borisova

Beilstein J. Nanotechnol. 2020, 11, 1381–1393, doi:10.3762/bjnano.11.122

• glutamate homeostasis and synaptic neurotransmission. Also, glutamate plays an important role in mediating the blood–brain barrier function and can be exploited for clinical translation [38]. It was shown that the conjugation of non-permeable drugs with glutamate may improve the brain delivery of the drug

• [39]. The neuronal release of glutamate modulates the blood–brain barrier function, through activation of N-methyl-ᴅ-aspartate (NMDA) receptors [40]. Glutamate increased intracellular calcium levels in endothelial cells and levels of nitrogen oxide (NO) around microvessels. These results can be

• considered in support of a mechanism of glutamate-induced activation of NMDA receptors in endothelial cells, which leads to calcium signaling and downstream NO production to promote blood–brain barrier permeability [38]. Thus, it may be expected that glutamate-conjugated γ-Fe2O3 nanoparticles can more easily

Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements

• Maria Suciu,
• Corina M. Ionescu,
• Alexandra Ciorita,
• Septimiu C. Tripon,
• Dragos Nica,
• Hani Al-Salami and
• Lucian Barbu-Tudoran

Beilstein J. Nanotechnol. 2020, 11, 1092–1109, doi:10.3762/bjnano.11.94

• inefficient methodology of use, and inconsistent results [94]. The potential toxicity could be put to a good use, though. Hybrid Fe3O4/Gd2O3 loaded with cisplatin and tagged with lactoferrin and RGD (a cell endocytosis small peptide) was proved in vitro and in vivo to cross the blood–brain barrier and target

Key for crossing the BBB with nanoparticles: the rational design

• Sonia M. Lombardo,
• Marc Schneider,
• Akif E. Türeli and
• Nazende Günday Türeli

Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72

• Central nervous system diseases are a heavy burden on society and health care systems. Hence, the delivery of drugs to the brain has gained more and more interest. The brain is protected by the blood–brain barrier (BBB), a selective barrier formed by the endothelial cells of the cerebral microvessels

• nanoparticles (AuNPs); blood–brain barrier (BBB); drug delivery; liposomes; nanomedicine; polymeric nanoparticles; solid lipid nanoparticles; superparamagnetic iron oxide nanoparticles (SPIONs); Introduction Neurological disorders and brain diseases are real burdens for modern societies and healthcare systems

• damaged by ischemia [2]. One of the main limitations for the treatment of neurological disorders is the difficulty to deliver drugs to the brain. The brain is surrounded by the blood–brain barrier (BBB), a selective barrier formed by the endothelial cells of the cerebral microvessels [3][4]. The surface

Frontiers in pharmaceutical nanotechnology

• Matthias G. Wacker

Beilstein J. Nanotechnol. 2019, 10, 2538–2540, doi:10.3762/bjnano.10.244

• science. They have fundamentally changed our understanding of the way dosage forms can facilitate drug therapy. Prof. Jörg Kreuter has been a pioneer in this research area and dedicated his life’s work to nanoparticle research and the blood–brain barrier [2]. One of his most outstanding discoveries, the

Microbubbles decorated with dendronized magnetic nanoparticles for biomedical imaging: effective stabilization via fluorous interactions

• Da Shi,
• Justine Wallyn,
• Dinh-Vu Nguyen,
• Francis Perton,
• Delphine Felder-Flesch,
• Sylvie Bégin-Colin,
• Mounir Maaloum and
• Marie Pierre Krafft

Beilstein J. Nanotechnol. 2019, 10, 2103–2115, doi:10.3762/bjnano.10.205

• MBs that incorporate IONPs are often made of polymers. For example, ultrasmall superparamagnetic iron oxide nanoparticles were embedded in the wall of poly(butyl cyanoacrylate)-based MBs, allowing the blood‒brain barrier penetration to be monitored [23]. Soft-shell colloids called lipospheres have

Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting

• Xianping Liu,
• Chengjuan Du,
• Haichun Li,
• Ting Jiang,
• Zimiao Luo,
• Zhiqing Pang,
• Daoying Geng and
• Jun Zhang

Beilstein J. Nanotechnol. 2019, 10, 1860–1872, doi:10.3762/bjnano.10.181

• construct the nanoprobe. Both in vitro and in vivo MR and optical imaging demonstrated that the as-constructed nanoprobe was effective and sensitive for tumor targeting with desirable biosafety. Given its desirable properties such as a 100 nm diameter (capable of penetration of the blood–brain barrier) and

Enhanced inhibition of influenza virus infection by peptide–noble-metal nanoparticle conjugates

• Zaid K. Alghrair,
• David G. Fernig and
• Bahram Ebrahimi

Beilstein J. Nanotechnol. 2019, 10, 1038–1047, doi:10.3762/bjnano.10.104

• the blood–brain barrier. Incubation of peripheral blood mononuclear cells with citrate and mixed-matrix gold nanoparticles demonstrates that the mixed-matrix ligand shell markedly reduces the reaction of the peripheral blood mononuclear cells to the nanoparticles [48]. Therefore, whilst it remains to

Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles

• Katrin Partikel,
• Robin Korte,
• Dennis Mulac,
• Hans-Ulrich Humpf and
• Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 1002–1015, doi:10.3762/bjnano.10.101

• attracted to NPs composed of hydrophobic core materials [30][31] resulting in a prolonged circulation time in blood [18]. Moreover, covalent attachment of apolipoprotein A–I and apolipoprotein E to the NP surface enables drug transport across the blood–brain barrier [32]. Here, both proteins were identified

Effects of gold and PCL- or PLLA-coated silica nanoparticles on brain endothelial cells and the blood–brain barrier

• Aniela Bittner,
• Angélique D. Ducray,
• Hans Rudolf Widmer,
• Michael H. Stoffel and
• Meike Mevissen

Beilstein J. Nanotechnol. 2019, 10, 941–954, doi:10.3762/bjnano.10.95

• , differentiation, nor did it induce inflammation. rBCEC4 cells showed blood–brain barrier characteristics including tight junctions. None of the nanoparticles altered the expression of tight junctions or impaired the blood–brain barrier permeability. The findings suggest that effects of these nanoparticles on the

• metabolic state of cells have to be further characterized before use for medical purposes. Keywords: blood–brain barrier; laser tissue soldering; nanomedicine; nanoparticle uptake; rBCEC4 cells; Introduction Nanotechnology is commonly used in various fields, such as agriculture and pharmaceutical industry

• and specialized structures such as the blood–brain barrier (BBB). To be able to safely employ LTS in nanomedicine, such unwanted effects need to be studied. Previously, we investigated effects of silica (Si-), namely silica-ICG/poly(ε-caprolactone) (PCL) and silica-ICG/poly(ε-caprolactone-poly(L

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• drug-loaded liposomes for glioblastoma treatment. Glioblastoma, localized in the brain, represents one of the major challenges in drug delivery due to the necessity to pass the blood brain barrier (BBB). BBB inhibits the passage of 98% of the medicines administered through the systemic route and

Bioinspired self-healing materials: lessons from nature

• Joseph C. Cremaldi and
• Bharat Bhushan

Beilstein J. Nanotechnol. 2018, 9, 907–935, doi:10.3762/bjnano.9.85

• glial cells (e.g., astrocytes and oligodendrocytes) exist to protect neurons and maintain homeostasis by removing material and minimizing damage to the body. However, this “protection” of the blood–brain barrier through glial scarring also creates barriers in the exact area where axons need to regrow

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

• Cem Varan and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

• , intravenous or orally administered chemotherapy drugs have very low efficacy due to challenges in reaching the brain and tumor area. The blood brain barrier (BBB) is the essential protection of the brain and only 1% of chemotherapeutic agents can pass this barrier without losing their pharmacological activity

Low uptake of silica nanoparticles in Caco-2 intestinal epithelial barriers

• Dong Ye,
• Mattia Bramini,
• Delyan R. Hristov,
• Sha Wan,
• Anna Salvati,
• Christoffer Åberg and
• Kenneth A. Dawson

Beilstein J. Nanotechnol. 2017, 8, 1396–1406, doi:10.3762/bjnano.8.141

• exposure routes, cellular barriers, such as the skin, the lung epithelium, the intestinal epithelium or the endothelium (including the blood-brain barrier), constitute one of the first sites of interactions of nanoparticles, whether intended as nanomedicines or not, with organisms. Thus in addressing the

• type of barrier, namely an in vitro model of the human endothelial blood brain barrier [14][15][51][52]. Thus, the low degree of uptake observed in the Caco-2 barrier may be a characteristic of this type of barrier and could be related to the more complex polarised nature of thicker epithelial layers

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• their potential as CAs exclusively in one of the MRI modes (T1 or T2). Further requirements consisted in better biocompatibility with the targeting of tumor cells, coupling with stem cells as well as crossing the cell membrane and blood–brain barrier. Finally, involving CNT activity in other diagnostic

• to penetrate the blood-brain barrier, particularly as a function of their diameter [68]. Magnetic resonance imaging The visual effect of the MRI CA candidate constitutes final verification which is most important for this technique. The quantitative results are provided in Table 3. The MWCNT hybrids

Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels

• Yue Zhang and
• Wan-Xi Yang

Beilstein J. Nanotechnol. 2016, 7, 675–684, doi:10.3762/bjnano.7.60

• , such as hormones. Blood is extensively circulated through those vessels and NPs in the blood may reside on the surface of vessels or go through some barriers, e.g., the blood–brain barrier [15], blood–gas barrier [16] and blood–testis barrier [17], and reach important organs which then may get

• ., blood–brain barrier, blood–gas barrier and blood–testis barrier). Plain nanoconjugates and nanosized vehicles are widely utilized as drug delivery tools to cross the blood–brain barrier [43]. Moreover, the translocation of gold nanoparticles through the air–blood barrier was found after a treatment with

• porcine blood–brain-barrier, both of which could contribute to the promotion of the TJ function [58]. Claudin-4 requires phosphorylation under certain concentrations of Mg2+ to proper localize to the tight junction [59] and it can be phosphorylated by protein kinase C (PKC) at Thr189 and Ser194, which